Print this page    •   Back to Web version of article

News Briefs
Lebanon: AIDS Drug Deal to Slash Treatment Costs

April 21, 2003

Lebanon's Ministry of Health signed an agreement Tuesday with leading international pharmaceutical company Merck Sharp and Dohme to provide AIDS drugs at 15 percent of the market rate. The agreement makes Lebanon a part of MSD's “Facilitating Accelerated Access” initiative for HIV/AIDS patients, a program to provide easier access to training education, testing and treatment of HIV/AIDS, as well as offer discounts on two AIDS mediations, Efavirenz and Indinavir. The new deal is expected to save the Health Ministry $1 million a year in drug bills. National AIDS Program head Mustafa Naqib said although there are 697 known AIDS cases in Lebanon, only about 180 are actually eligible for the treatment. The program registered 47 new cases of HIV/AIDS in 2002.

Back to other CDC news for April 21, 2003

Previous Updates

Excerpted from:
Daily Star (Lebanon)
04.18.2003; Maha Al-Azar




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art29758.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.